Literature DB >> 22604198

Acquired haemophilia secondary to ivabradine presenting with acute respiratory distress syndrome.

Moussa Albert Riachy1, Fadi Nasr, Rabih Azar.   

Abstract

The authors present the case of a 72-year-old patient who presented with severe dyspnoea, scant haemoptysis, pronounced desaturation and bilateral haematomas on the upper limbs. Chest radiography showed bilateral infiltrates mainly in the lower lobes. The patient's prothrombin time, and platelet count were normal. However, the activated partial thromboplastin time showed a prolongation that was not reversed on a correction study. Factor VIII (FVIII) levels were very low and evidence of FVIII inhibitor was found. The patient had started taking ivabradine 2 months earlier, and the diagnosis of idiosyncratic acquired haemophilia was established. The patient was treated with volume expansion therapy, high levels of oxygen, multiple transfusions, methylprednisolone, desmopressine and rituximab. On the 3rd day, the patient showed progressive amelioration of his dyspnoea, oxygen needs and chest infiltrates. On the 7th day, the patient was discharged.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22604198      PMCID: PMC3339166          DOI: 10.1136/bcr.01.2012.5506

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

Authors:  Julio Delgado; Victor Jimenez-Yuste; Fernando Hernandez-Navarro; Ana Villar
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

Review 2.  Acquired hemophilia.

Authors:  L N Boggio; D Green
Journal:  Rev Clin Exp Hematol       Date:  2001-12

Review 3.  Acquired hemophilia A: a concise review.

Authors:  Massimo Franchini; Giorgio Gandini; Tiziana Di Paolantonio; Guglielmo Mariani
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

4.  Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.

Authors:  W J Chng; C Sum; P Kuperan
Journal:  Singapore Med J       Date:  2005-09       Impact factor: 1.858

Review 5.  The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

Authors:  Charles R M Hay; S Brown; P W Collins; D M Keeling; R Liesner
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 6.  Acquired factor VIII inhibitors: pathophysiology and treatment.

Authors:  Alice D Ma; Daniel Carrizosa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 7.  Acquired inhibitors.

Authors:  A J Cohen; C M Kessler
Journal:  Baillieres Clin Haematol       Date:  1996-06
  7 in total
  3 in total

Review 1.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

2.  Acquired hemophilia A in a patient treated by Ginkgo-dipyridamolum.

Authors:  Jinbo Liu; Hongyu Wang; Guangyun Shang; Lichun Wang; Hongwei Zhao; Huan Liu
Journal:  Clin Case Rep       Date:  2017-01-14

3.  Acute airway compromise and coagulopathy: a rare presentation of acquired haemophilia A.

Authors:  William Byron Howden; Jonathan Kam; Nicholas Leith; Shashinder Singh
Journal:  BMJ Case Rep       Date:  2020-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.